Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach

INTRODUCTION: While atenolol is an effective antihypertensive agent, its use is also associated with adverse events including hyperglycemia and incident diabetes that may offset the benefits of blood pressure lowering. By combining metabolomic and genomic data acquired from hypertensive individuals...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Metabolomics
Main Authors: de Oliveira, Felipe A., Shahin, Mohamed H., Gong, Yan, McDonough, Caitrin W., Beitelshees, Amber L., Gums, John G., Chapman, Arlene B., Boerwinkle, Eric, Turner, Stephen T., Frye, Reginald F., Fiehn, Oliver, Kaddurah-Daouk, Rima, Johnson, Julie A., Cooper-DeHoff, Rhonda M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310671/
https://ncbi.nlm.nih.gov/pubmed/28217400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1076-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados